Amyotrophic lateral sclerosis: Oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes

Neurology

Volumn 47, Issue 4, 1996, Pages 1060-1064

  Curti, D ^a   Malaspina, A ^a   Facchetti, G ^a   Camana, C ^b   Mazzini, L ^b   Tosca, P ^a   Zerbi, F ^a   Ceroni, M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Clinica Lavoro Rehabilitation Ctr   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CATALASE; CYTOCHROME C OXIDASE; LACTIC ACID; POTASSIUM ION;

ADULT; AEROBIC METABOLISM; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0029809528     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.4.1060     Document Type: Article

References (41)

1. Rosen DR, Siddique T, Patterson D, et al. Mutation in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
2. De Belleroche J, Virgo L, Rossi M, Stiner TJ. Advances in ALS research through brain banking. Neuropathol Appl Neurobiol 1995;21(Suppl):24-25.
3. Deng H-X, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu/Zn superoxide dismutase. Science 1993;261:1047-1051.
4. Bowling AC, Schulz JB, Brown RH, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993;61:2322-2325.
5. Dioszeghy P, Imre S, Mechler F. Lipid peroxidation and superoxide dismutase activity in muscle and erythrocytes in adult muscular dystrophy and neurogenic atrophies. Eur Arch Psychiatry Neurol Sci 1989;238:175-177.
6. Robberecht W, Sapp P, Viaene MK, et al. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1994;62:384-387.
7. Puymirat J, Cossette L, Gosselin F, Bouchard J-P. Red blood cell Cu/Zn superoxide dismutase activity in sporadic amyotrophic lateral sclerosis. J Neurol Sci 1994;127:121-123.
8. Bracco F, Scarpa M, Rigo A, Battistini L. Determination of superoxide dismutase activity by the polarographic method of catalytic currents in the cerebrospinal fluid of aging brain and neurologic degenerative diseases. Proc Soc Exp Biol Med 1991; 196:36-41.
9. Iwasaki Y, Ikeda K, Kinoshita M. Decreased cerebrospinal fluid superoxide dismutase in amyotrophic lateral sclerosis. Lancet 1993;342:1118.
10. Donaldson D, Fernando S, Murphy PL, et al. Blood superoxide dismutase, catalase and glutathione peroxidase activity in amyotrophic lateral sclerosis. Neurology 1995;45:221.
11. Bergeron C, Muntasser S, Somerville MJ, et al. Copper/zinc superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis motorneurons. Brain Res 1994; 659:272-276.
12. Brown RH. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995;80:687-692.
13. Rothstein JD, Martin IJ, Kuncl RW. Decreased glutamate transport by brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992;326:1464-1468.
14. Rothstein JD, Kammen MV, Levey AI, et al. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84.
15. Plaitakis A, Caroscio JT. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 1987;22:575-579.
16. Plaitakis A, Constantakakis E, Smith J. The neuroexcytotoxic amino acid glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann Neurol 1988;24:446-449.
17. Perry TL, Hansen S, Jones K. Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 1987;37:1845-1848.
18. Tsai G, Stauch-Slusher B, Sim L, et al. Reduction in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS. Brain Res 1991;556:151-156.
19. Ratan RR, Murphy TH, Baraban JM. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 1994; 62:376-379.
20. 28K immunoreactivity in a hybrid motoneuron cell line prevents ALS IgG induced cytotoxicity. Soc Neurosci Abstr 1994; part 1:431.
21. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994; 91:10771-10778.
22. Benzi G, Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 1995;16:661-674.
23. Bowling AC, Beal MF. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 1995;56:1151-1171.
24. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-366.
25. Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to aging and degenerative diseases. Lancet 1989;1:642-645.
26. World Federation of Neurology Research Group on Neuromuscular Disorders. El Escorial WFN Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. J Neurol Sci 1994;124(Suppl): 96-107.
27. Norris FH, Calanchini PR, Fallat RJ, et al. The administration of guanidine in ALS. Neurology 1974;24:721-728.
28. Ferguson-Miller S, Brautigan DL, Margoliash E. Correlation of the kinetics of electron transfer activity of various eukaryotic cytochromes c with binding to mitochondrial cytochrome oxidase. J Biol Chem 1976;251:1104-1113.
29. Wharton DC, Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. In: Estabrook RW, Pullman ME, eds. Methods in enzymology. New York and London: Academic Press, 1967: Vol X:245-246.
30. Curti D, Giangaré MC, Redolfi ME, Fugaccia I, Benzi G. Agerelated modifications of cytochrome c oxidase activity in discrete brain regions. Mech Ageing Dev 1990;55:171-180.
31. Del Rio LA, Ortega MG, López AL, Gorge JL. A more sensitive modification of the catalase assay with the Clark oxygen electrode. Anal Biochem 1977;80:409-415.
32. Gutman I, Wahlefeld AW. L-(+)-lactate. Determination with lactate dehydrogenase and NAD. In: Bergmeyer HU, ed. Methods in enzymatic analysis. New York: Academic Press, 1974;3:1464-1468.
33. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450.
34. Aspin J, Harrison R, Jehanli A, Lunt GL, Campbell M. Stimulation by mitogens and neuronal membranes of lymphocytes from patients with motor neuron disease. J Neurol 1986;11: 31-40.
35. Nakano Y, Hirayama K, Terao K. Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Arch Neurol 1987;44:103-106.
36. Hirano A, Donnenfeld H, Sasaki S, Nakano Y. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1984;43:461-470.
37. Witt MR, Gredal O, Dekermendjian K, et al. Calcium homeostasis in fibroblasts from patients with amyotrophic lateral sclerosis. J Neurol Sci 1994;126:206-212.
38. Munns PL, Leach KL. Two novel antioxidants, U74006F and U7851F, inhibit oxidant-stimulated calcium influx. Free Radic Biol Med 1995;18:467-478.
39. 2+ and membrane potential. Arch Biochem Biophys 1987;259:457-465.
40. 2+ flux in pulmonary vascular endothelial cells. Am J Physiol 1991;260:H459-H556.
41. 2+ ions is stimulated by t-butyl hydroperoxide and mediated by reactive oxygen species generated by mitochondria. Free Radic Biol Med 1995;18:479-486.